scholarly journals TOX as a potential target for immunotherapy in lymphocytic malignancies

2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Chaofeng Liang ◽  
Shuxin Huang ◽  
Yujie Zhao ◽  
Shaohua Chen ◽  
Yangqiu Li

AbstractTOX (thymocyte selection-associated HMG BOX) is a member of a family of transcriptional factors that contain the highly conserved high mobility group box (HMG-box) region. Increasing studies have shown that TOX is involved in maintaining tumors and promoting T cell exhaustion. In this review, we summarized the biological functions of TOX and its contribution as related to lymphocytic malignancies. We also discussed the potential role of TOX as an immune biomarker and target in immunotherapy for hematological malignancies.

2019 ◽  
Vol 32 (2) ◽  
pp. 89-94 ◽  
Author(s):  
Nafise Yaghouti ◽  
Reza Boostani ◽  
Asadollah Mohamamdi ◽  
Zohreh Poursina ◽  
Seyed Abdolrahim Rezaee ◽  
...  

2021 ◽  
Vol 229 ◽  
pp. 1-7
Author(s):  
Yanmin Cheng ◽  
Zhaozhao Shao ◽  
Li Chen ◽  
Qiaoyu Zheng ◽  
Qiqi Zhang ◽  
...  

2000 ◽  
Vol 164 (6) ◽  
pp. 3157-3168 ◽  
Author(s):  
S. Roy Himes ◽  
Raymond Reeves ◽  
Joanne Attema ◽  
Mark Nissen ◽  
Ying Li ◽  
...  

Pneumologie ◽  
2012 ◽  
Vol 66 (06) ◽  
Author(s):  
H Xu ◽  
D Zabini ◽  
A Olschewski ◽  
G Kwapiszewska ◽  
LM Marsh

2014 ◽  
Vol 58 (01) ◽  
pp. 69-75 ◽  
Author(s):  
X. Q. HOU ◽  
J. L. QIN ◽  
X. X. ZHENG ◽  
L. WANG ◽  
S. T. YANG ◽  
...  

2006 ◽  
Vol 19 (1) ◽  
pp. 3-9 ◽  
Author(s):  
Haichao Wang ◽  
Mary F. Ward ◽  
Xue-Gong Fan ◽  
Andrew E. Sama ◽  
Wei Li

2008 ◽  
Vol 178 (8) ◽  
pp. 822-831 ◽  
Author(s):  
Steven M. Rowe ◽  
Patricia L. Jackson ◽  
Gang Liu ◽  
Mathew Hardison ◽  
Alessandra Livraghi ◽  
...  

2018 ◽  
Vol 55 (4) ◽  
pp. 244-254
Author(s):  
Sera Gonelevue ◽  
Abhirup Bandyopadhyay ◽  
Saumya Bhagat ◽  
Md Iqbal Alam ◽  
Gausal A. Khan

Sign in / Sign up

Export Citation Format

Share Document